#Assessment, #management and #prevention of exacerbations are anticipated to change significantly in the future. As described, the heterogeneity in #mechanisms and #outcomes of #COPD #exacerbations can be resolved by grouping them aetiologically. Therefore, the main challenge to tackle is the development and validation of accurate #biomarkers for early characterisation of the different types of exacerbations
